Krystene Woodard

Krystene Woodard is an experienced professional in the pharmaceutical and medical affairs sectors, currently serving as the Director of Medical Affairs for Obesity at Novo Nordisk since October 2018. Prior to this role, Woodard held various leadership positions at Shire, including Head of US Field Medical Effectiveness and Team Lead for Neuroscience & Ophthalmics Medical Science Liaisons. Woodard's career also includes significant roles at Abbott Laboratories and Sankyo Pharma, where responsibilities involved managing medical science liaisons and strategic initiatives. Woodard began an academic career at Xavier University of Louisiana College of Pharmacy as an Assistant Clinical Professor and holds a Pharm.D. degree from the same institution, where involvement in Delta Sigma Theta Sorority, Inc., Kappa Psi Pharmacy Fraternity, and student government was notable.